New Resolve in Inflammation

A report in Nature Immunology describes how the endogenous molecule resolvin E1 promotes resolution of airway inflammation in mice and provides a rationale for using this molecule as a therapeutic agent to treat asthma. Company and institution representatives interviewed for this story agreed that the findings could have multiple applications in the inflammation space. Opinions varied, however, on whether resolvin E1 was a potential therapeutic agent to treat asthma in humans.

The research team on the Nature Immunology paper was led by Bruce Levy, associate professor of medicine at Harvard Medical School and Brigham and Women's Hospital.¹...